Overland Park, KSNCT07395687Now EnrollingIRB Ready

Overweight Clinical Trial in Overland Park, KS

Access cutting-edge overweight treatment through this clinical trial at a research site in Overland Park. Study-provided care at no cost to qualified participants.

Sponsored by Novo Nordisk A/S

Quick Self-Assessment

See if you qualify for this Overland Park location

Preparing your pre-screening questions…

Expert Care in Overland Park

Access overweight specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related overweight treatment provided free

Apply for This Overland Park Location

Check if you qualify for this overweight clinical trial in Overland Park, KS

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Overland Park

    Convenient for KS residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Overland Park site if eligible
  4. 4Begin participation

About This Overweight Study in Overland Park

The purpose of this clinical study is to find out if UBT251 is safe and effective for treating people who are living with overweight or obesity. Participants will get either UBT251 (the treatment being tested) or Placebo (a treatment that has no active medicine in it), which treatment participants get is decided by chance.

Sponsor: Novo Nordisk A/S

Who Can Participate

Inclusion Criteria

Male or female (sex at birth).
For Part C: Japanese, Chinese or non-Asian participants (all self-reported):
For Japanese participants: both parents of Japanese descent.
For Chinese participants: both parents of Chinese descent.
For non-Asian participants: both parents of non-Asian descent (non-Asian is defined as of countries outside of Asia).
Age at the time of signing the informed consent:
For Part A: 18-55 years (both inclusive)
For Part B: 18-65 years (both inclusive)
For Part C: 18-55 years (both inclusive).
BMI at screening (overweight and obesity should be due to excess adipose tissue, as judged by the investigator):
For Part A: 27.0-39.9 kilogram per meter square (kg/m\^2) (both inclusive)
For Part B: 30.0-50.0 kg/m\^2 (both inclusive)
For Part C: 24-34.9 kg/m\^2 (both inclusive)
Considered eligible based on the medical history, physical examination, and the results of vital signs, electrocardiogram (ECG), and clinical laboratory tests performed during the screening visit, as judged by the investigator.

Exclusion Criteria

Known or suspected hypersensitivity to study intervention(s) or related products.
Treatment with any marketed product containing compounds with glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) or glucagon receptor agonism within 90 days before screening.
Any condition, unwillingness or inability, which in the investigator's opinion might jeopardise the participant's safety or compliance with the protocol.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Overland Park?

Yes, this clinical trial (NCT07395687) has an active research site in Overland Park, KS that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Overweight Treatment Options in Overland Park, KS

If you're searching for overweight treatment options in Overland Park, KS, this clinical trial (NCT07395687) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Overland Park research site is actively enrolling participants for this clinical trial. You'll receive care from experienced overweight specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all overweight clinical trials near you to find additional studies recruiting in your area.

More Obesity Trials in Overland Park, KS

See all obesity clinical trials recruiting in Overland Park — not just this study.

Browse Obesity Trials in Overland Park →

Browse More Trials by Condition

Obesity TrialsAll Conditions →

Ready to Join in Overland Park?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Overland Park, KS